How the immune system detects lipid antigens

Progress in Lipid Research

Volumn 49, Issue 2, 2010, Pages 120-127

  De Libero, Gennaro ^a   Mori, Lucia ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Antigen presentation; CD1; Microbial lipids; Self lipids; T cell receptor; T lymphocytes

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ANTIGEN; CD1 ANTIGEN; CD1B ANTIGEN; CD1C ANTIGEN; CD1D ANTIGEN; CD1E ANTIGEN; GLYCOLIPID; LIPID; LIPID BINDING PROTEIN; LIPID TRANSFER PROTEIN; LIPOARABINOMANNAN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYCOLIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; SPHINGOLIPID ACTIVATOR PROTEIN; STEROL CARRIER PROTEIN 2; SULFATIDE; T LYMPHOCYTE RECEPTOR; T6 ANTIGEN; UNCLASSIFIED DRUG;

AGELAS; ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIGEN STRUCTURE; ANTIGENICITY; AUTOIMMUNITY; BACTERIAL INFECTION; BORRELIA; CANCER EPIDEMIOLOGY; CELL MEMBRANE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DEGRADATION KINETICS; EHRLICHIA; ENDOSOME; HUMAN; HYDROPHOBICITY; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOREGULATION; IMMUNOTHERAPY; INFECTION RESISTANCE; LIPID TRANSPORT; MEMBRANE TRANSPORT; MYCOBACTERIUM; NATURAL KILLER CELL; NONHUMAN; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SPHINGOMONAS; T LYMPHOCYTE; TUMOR IMMUNITY;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, BACTERIAL; ANTIGENS, CD1; LIPIDS; T-LYMPHOCYTES;

BACTERIA (MICROORGANISMS);

EID: 76549128920     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plipres.2009.10.002     Document Type: Review

References (73)

1. Beckman E.M., Porcelli S.A., Morita C.T., Beha-r S.M., Furlong S.T., and Brenner M.B. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 372 (1994) 691-694
2. Porcelli S., Brenner M.B., Greenstein J.L., Balk S.P., Terhorst C., and Bleicher P.A. Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature 341 (1989) 447-450
3. Zeng Z., Castano A.R., Segelke B.W., Stura E.A., Peterson P.A., and Wilson I.A. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277 (1997) 339-345
4. Porcelli S.A., and Modlin R.L. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Ann Rev Immunol 17 (1999) 297-329
5. De Libero G., and Mori L. Recognition of lipid antigens by T cells. Nat Rev Immunol 5 (2005) 485-496
6. Moody D.B., Zajonc D.M., and Wilson I.A. Anatomy of CD1-lipid-antigen complexes. Nat Rev Immunol 5 (2005) 1-14
7. Brigl M., and Brenner M.B. CD1: antigen presentation and T cell function. Ann Rev Immunol 22 (2004) 817-890
8. Relloso M., Cheng T.Y., Im J.S., Parisini E., Roura-Mir C., DeBono C., et al. pH-dependent interdomain tethers of CD1b regulate its antigen capture. Immunity 28 (2008) 774-786
9. Zajonc D.M., Elsliger M.A., Teyton L., and Wilson I.A. Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A. Nat Immunol 4 (2003) 808-815
10. Shamshiev A., Gober H.J., Donda A., Mazorra Z., Mori L., and De Libero G. Presentation of the same glycolipid by different CD1 molecules. J Exp Med 195 (2002) 1013-1021
11. Manolova V., Kistowska M., Paoletti S., Baltariu G.M., Bausinger H., Hanau D., et al. Functional CD1a is stabilized by exogenous lipids. Eur J Immunol 36 (2006) 1083-1092
12. Cheng T.Y., Relloso M., Van Rhijn I., Young D.C., Besra G.S., Briken V., et al. Role of lipid trimming and CD1 groove size in cellular antigen presentation. Embo J 25 (2006) 2989-2999
13. Batuwangala T., Shepherd D., Gadola S.D., Gibson K.J., Zaccai N.R., Fersht A.R., et al. The crystal structure of human CD1b with a bound bacterial glycolipid. J Immunol 172 (2004) 2382-2388
14. Ernst W.A., Maher J., Cho S., Niazi K.R., Chatterjee D., Moody D.B., et al. Molecular interaction of CD1b with lipoglycan antigens. Immunity 8 (1998) 331-340
15. Kronenberg M., and Sullivan B.A. Acid test: lipid antigens get into the groove. Immunity 28 (2008) 727-729
16. Garcia-Alles L.F., Versluis K., Maveyraud L., Vallina A.T., Sansano S., Bello N.F., et al. Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b. Embo J 25 (2006) 3684-3692
17. Zajonc D.M., Cantu III C., Mattner J., Zhou D., Savage P.B., Bendelac A., et al. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat Immunol 6 (2005) 810-818
18. Borg N.A., Wun K.S., Kjer-Nielsen L., Wilce M.C., Pellicci D.G., Koh R., et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448 (2007) 44-49
19. Agea E., Russano A., Bistoni O., Mannucci R., Nicoletti I., Corazzi L., et al. Human CD1-restricted T cell recognition of lipids from pollens. J Exp Med 202 (2005) 295-308
20. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278 (1997) 1626-1629
21. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu III C., Zhou D., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434 (2005) 525-529
22. Kinjo Y., Wu D., Kim G., Xing G.W., Poles M.A., Ho D.D., et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434 (2005) 520-525
23. Kinjo Y., Tupin E., Wu D., Fujio M., Garcia-Navarro R., Benhnia M.R., et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7 (2006) 978-986
24. De Libero G., and Mori L. Structure and biology of self lipid antigens. Curr Top Microbiol Immunol 314 (2007) 51-72
25. Shamshiev A., Donda A., Prigozy T.I., Mori L., Chigorno V., Benedict C.A., et al. The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity 13 (2000) 255-264
26. Shamshiev A., Donda A., Carena I., Mori L., Kappos L., and De Libero G. Self glycolipids as T-cell autoantigens. Eur J Immunol 29 (1999) 1667-1675
27. Zhou D., Mattner J., Cantu III C., Schrantz N., Yin N., Gao Y., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306 (2004) 1786-1789
28. Yuan W., Kang S.J., Evans J.E., and Cresswell P. Natural lipid ligands associated with human CD1d targeted to different subcellular compartments. J Immunol 182 (2009) 4784-4791
29. Cox D., Fox L., Tian R., Bardet W., Skaley M., Mojsilovic D., et al. Determination of cellular lipids bound to human CD1d molecules. PLoS One 4 (2009) e5325
30. Chang D.H., Deng H., Matthews P., Krasovsky J., Ragupathi G., Spisek R., et al. Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer. Blood 112 (2008) 1308-1316
31. van den Elzen P., Garg S., Leon L., Brigl M., Leadbetter E.A., Gumperz J.E., et al. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437 (2005) 906-910
32. Zhou D., Cantu III C., Sagiv Y., Schrantz N., Kulkarni A.B., et al. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303 (2004) 523-527
33. Kang S.J., and Cresswell P. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat Immunol 5 (2004) 175-181
34. Winau F., Schwierzeck V., Hurwitz R., Remmel N., Sieling P.A., Modlin R.L., et al. Saposin C is required for lipid presentation by human CD1b. Nat Immunol 5 (2004) 169-174
35. Mukherjee S., and Maxfield F.R. Lipid and cholesterol trafficking in NPC. Biochim Biophys Acta 1685 (2004) 28-37
36. Sun X., Marks D.L., Park W.D., Wheatley C.L., Puri V., O'Brien J.F., et al. Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1. Am J Human Genet 68 (2001) 1361-1372
37. Sagiv Y., Hudspeth K., Mattner J., Schrantz N., Stern R.K., Zhou D., et al. Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein. J Immunol 177 (2006) 26-30
38. Schumann J., Facciotti F., Panza L., Michieletti M., Compostella F., Collmann A., et al. Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism. Eur J Immunol 37 (2007) 1431-1441
39. Schrantz N., Sagiv Y., Liu Y., Savage P.B., Bendelac A., and Teyton L. The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells. J Exp Med 204 (2007) 841-852
40. Angenieux C., Salamero J., Fricker D., Cazenave J.P., Goud B., Hanau D., et al. Characterization of CD1e, a third type of CD1 molecule expressed in dendritic cells. J Biol Chem 275 (2000) 37757-37764
41. de la Salle H., Mariotti S., Angenieux C., Gilleron M., Garcia-Alles L.F., Malm D., et al. Assistance of microbial glycolipid antigen processing by CD1e. Science 310 (2005) 1321-1324
42. Jayawardena-Wolf J., Benlagha K., Chiu Y.H., Mehr R., and Bendelac A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15 (2001) 897-908
43. Sloma I., Zilber M.T., Vasselon T., Setterblad N., Cavallari M., Mori L., et al. Regulation of CD1a surface expression and antigen presentation by invariant chain and lipid rafts. J Immunol 180 (2008) 980-987
44. Sieling P.A., Porcelli S.A., Duong B.T., Spada F., Bloom B.R., Diamond B., et al. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J Immunol 165 (2000) 5338-5344
45. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., and Van Kaer L. NKT cells: what's in a name?. Nat Rev Immunol 4 (2004) 231-237
46. Bendelac A., Savage P.B., and Teyton L. The Biology of NKT Cells. Ann Rev Immunol (2006) 5
47. Bendelac A., Rivera M.N., Park S.H., and Roark J.H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Ann Rev Immunol 15 (1997) 535-562
48. Jahng A., Maricic I., Aguilera C., Cardell S., Halder R.C., and Kumar V. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med 199 (2004) 947-957
49. Terabe M., Matsui S., Noben-Trauth N., Chen H., Watson C., Donaldson D.D., et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 1 (2000) 515-520
50. Godfrey D.I., and Berzins S.P. Control points in NKT-cell development. Nat Rev Immunol 17 (2008) 505
51. Savage A.K., Constantinides M.G., Han J., Picard D., Martin E., Li B., et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29 (2008) 1
52. Kovalovsky D., Uche O.U., Eladad S., Hobbs R.M., Yi W., Alonzo E., et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol 9 (2008) 1055
53. Pasquier B., Yin L., Fondaneche M.C., Relouzat F., Bloch-Queyrat C., Lambert N., et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J Exp Med 201 (2005) 695-701
54. Nichols K.E., Hom J., Gong S.Y., Ganguly A., Ma C.S., Cannons J.L., et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat Med 11 (2005) 340-345
55. Chung B., Aoukaty A., Dutz J., Terhorst C., and Tan R. Cutting edge: signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J Immunol 174 (2005) 3153-3157
56. Kronenberg M. Toward and understanding of NKT cell biology: progress and paradoxes. Ann Rev Immunol 26 (2005) 877-900
57. Scott-Browne J.P., Matsuda J.L., Mallevaey T., White J., Borg N.A., McCluskey J., et al. Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat Immunol 8 (2007) 1105-1113
58. Wun K.S., Borg N.A., Kjer-Nielsen L., Beddoe T., Koh R., Richardson S.K., et al. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J Exp Med 205 (2008) 939-949
59. Cantu III C., Benlagha K., Savage P.B., Bendelac A., and Teyton L. The paradox of immune molecular recognition of alpha-galactosylceramide: low affinity, low specificity for CD1d, high affinity for alpha beta TCRs. J Immunol 170 (2003) 4673-4682
60. Sidobre S., Hammond K.J., Benazet-Sidobre L., Maltsev S.D., Richardson S.K., Ndonye R.M., et al. The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc Natl Acad Sci USA 101 (2004) 12254-12259
61. Gadola S.D., Koch M., Marles-Wright J., Lissin N.M., Shepherd D., Matulis G., et al. Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors. J Exp Med 203 (2006) 699-710
62. McCarthy C., Shepherd D., Fleire S., Stronge V.S., Koch M., Illarionov P.A., et al. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med 204 (2007) 1131-1144
63. Melian A., Watts G.F., Shamshiev A., De Libero G., Clatworthy A., Vincent M., et al. Molecular recognition of human CD1b antigen complexes: evidence for a common pattern of interaction with alpha beta TCRs. J Immunol 165 (2000) 4494-4504
64. Sidobre S., Naidenko O.V., Sim B.C., Gascoigne N.R., Garcia K.C., and Kronenberg M. The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J Immunol 169 (2002) 1340-1348
65. Moody D.B., Reinhold B.B., Guy M.R., Beckman E.M., Frederique D.E., Furlong S.T., et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278 (1997) 283-286
66. Moody D.B., Guy M.R., Grant E., Cheng T.Y., Brenner M.B., Besra G.S., et al. CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J Exp Med 192 (2000) 965-976
67. Grant E.P., Beckman E.M., Behar S.M., Degano M., Frederique D., Besra G.S., et al. Fine specificity of TCR complementarity-determining region residues and lipid antigen hydrophilic moieties in the recognition of a CD1-lipid complex. J Immunol 168 (2002) 3933-3940
68. de Jong A., Arce E.C., Cheng T.Y., van Summeren R.P., Feringa B.L., Dudkin V., et al. CD1c presentation of synthetic glycolipid antigens with foreign alkyl branching motifs. Chem Biol 14 (2007) 1232-1242
69. Layre E., Collmann A., Bastian M., Mariotti S., Czaplicki J., Prandi J., et al. Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted T cells. Chem Biol 16 (2009) 82-92
70. Miyamoto K., Miyake S., and Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413 (2001) 531-534
71. Yu K.O., Im J.S., Molano A., Dutronc Y., Illarionov P.A., Forestier C., et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc Natl Acad Sci USA 102 (2005) 3383-3388
72. Zajonc D.M., Savage P.B., B endelac A., Wilson I.A., and Teyton L. Crystal structures of mouse CD1d-iGb3 complex and its cognate Valpha14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids. J Mol Biol 377 (2008) 1104-1116
73. Prigozy T.I., Naidenko O., Qasba P., Elewaut D., Brossay L., Khurana A., et al. Glycolipid antigen processing for presentation by CD1d molecules. Science 291 (2001) 664-667